Your browser doesn't support javascript.
loading
Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention.
Moorthie, Sowmiya; Babb de Villiers, Chantal; Burton, Hilary; Kroese, Mark; Antoniou, Antonis C; Bhattacharjee, Proteeti; Garcia-Closas, Montserrat; Hall, Per; Schmidt, Marjanka K.
Afiliación
  • Moorthie S; PHG Foundation, University of Cambridge, Cambridge, UK; Cambridge Public Health, University of Cambridge School of Clinical Medicine, Forvie Site, Cambridge Biomedical Campus, Cambridge CB2 0SR, United Kingdom. Electronic address: Sowmiya.moorthie@phgfoundation.org.
  • Babb de Villiers C; PHG Foundation, University of Cambridge, Cambridge, UK.
  • Burton H; PHG Foundation, University of Cambridge, Cambridge, UK.
  • Kroese M; PHG Foundation, University of Cambridge, Cambridge, UK.
  • Antoniou AC; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bhattacharjee P; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Garcia-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, USA.
  • Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Prev Med ; 159: 107075, 2022 06.
Article en En | MEDLINE | ID: mdl-35526672
ABSTRACT
Advances in knowledge about breast cancer risk factors have led to the development of more comprehensive risk models. These integrate information on a variety of risk factors such as lifestyle, genetics, family history, and breast density. These risk models have the potential to deliver more personalised breast cancer prevention. This is through improving accuracy of risk estimates, enabling more effective targeting of preventive options and creating novel prevention pathways through enabling risk estimation in a wider variety of populations than currently possible. The systematic use of risk tools as part of population screening programmes is one such example. A clear understanding of how such tools can contribute to the goal of personalised prevention can aid in understanding and addressing barriers to implementation. In this paper we describe how emerging models, and their associated tools can contribute to the goal of personalised healthcare for breast cancer through health promotion, early disease detection (screening) and improved management of women at higher risk of disease. We outline how addressing specific challenges on the level of communication, evidence, evaluation, regulation, and acceptance, can facilitate implementation and uptake.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Prev Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Prev Med Año: 2022 Tipo del documento: Article